Matches in Wikidata for { <http://www.wikidata.org/entity/Q64139342> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q64139342 description "clinical trial" @default.
- Q64139342 description "ensayu clínicu" @default.
- Q64139342 description "klinisch onderzoek" @default.
- Q64139342 description "клінічне випробування" @default.
- Q64139342 description "կլինիկական փորձարկում" @default.
- Q64139342 name "PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)" @default.
- Q64139342 type Item @default.
- Q64139342 label "PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)" @default.
- Q64139342 prefLabel "PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)" @default.
- Q64139342 P1132 Q64139342-D33397E2-2DE4-41F6-8542-3978278C4042 @default.
- Q64139342 P1476 Q64139342-E081AE12-3999-46E0-B6AC-BAD5E1EA4590 @default.
- Q64139342 P17 Q64139342-746AD0E0-0969-4508-9584-0BBBC45BAE2F @default.
- Q64139342 P1813 Q64139342-D8565712-2FDA-4623-9D04-FBD70749B512 @default.
- Q64139342 P2899 Q64139342-F879E5DE-3404-41A1-95CD-53AA7B6BE95D @default.
- Q64139342 P3098 Q64139342-9C99DCDB-A7F1-43AA-918A-26563B15D94C @default.
- Q64139342 P31 Q64139342-222AE90C-A694-481F-B285-C32CE1F9871E @default.
- Q64139342 P580 Q64139342-80495AA9-22B3-4EBA-8EA1-B0D47BA72597 @default.
- Q64139342 P582 Q64139342-3FA6AEED-751A-427B-906E-433E6F1EE11E @default.
- Q64139342 P6099 Q64139342-6D0D89D5-0D78-4753-BE06-5E33042974C3 @default.
- Q64139342 P6153 Q64139342-1A26D8A3-381F-4412-BBB0-6E4979B65088 @default.
- Q64139342 P6153 Q64139342-1D8360A3-D6DF-4FA7-8FE1-0F647D299269 @default.
- Q64139342 P6153 Q64139342-1E0E4D16-4092-4FB3-ADCF-3C550B66EDDC @default.
- Q64139342 P6153 Q64139342-2696A947-A192-4A71-BFDF-2F320C4B4375 @default.
- Q64139342 P6153 Q64139342-3176E171-DDB2-48B6-84FD-C87179C7ED28 @default.
- Q64139342 P6153 Q64139342-775633DA-7170-4091-AD8B-A74317F31E99 @default.
- Q64139342 P6153 Q64139342-A9E199B3-7E35-48D3-86B6-08A246C3B314 @default.
- Q64139342 P6153 Q64139342-C8E0D07C-C706-4BA9-B2F5-F046253E2243 @default.
- Q64139342 P6153 Q64139342-CC08867D-9071-441A-BAB9-227D46C3F332 @default.
- Q64139342 P6153 Q64139342-E8E1D582-F8C4-46F2-905B-178CCD4FEB70 @default.
- Q64139342 P8363 Q64139342-8C45B627-87B1-45F1-A26C-32BB13AA7242 @default.
- Q64139342 P1132 "+198" @default.
- Q64139342 P1476 "International,Multicenter,Randomized,Open-label, Phase II to Evaluate the Efficacy and Safety of Continuation of Palbociclib+2nd Line Endocrine Therapy in HR+/HER2- ABC Patients Who Had Clinical Benefit During 1st Line Palbociclib." @default.
- Q64139342 P17 Q29 @default.
- Q64139342 P1813 "PALMIRA" @default.
- Q64139342 P2899 "+18" @default.
- Q64139342 P3098 "NCT03809988" @default.
- Q64139342 P31 Q30612 @default.
- Q64139342 P580 "2019-04-05T00:00:00Z" @default.
- Q64139342 P582 "2022-08-01T00:00:00Z" @default.
- Q64139342 P6099 Q42824440 @default.
- Q64139342 P6153 Q11682611 @default.
- Q64139342 P6153 Q20105388 @default.
- Q64139342 P6153 Q219694 @default.
- Q64139342 P6153 Q30293330 @default.
- Q64139342 P6153 Q4865798 @default.
- Q64139342 P6153 Q50562360 @default.
- Q64139342 P6153 Q5110676 @default.
- Q64139342 P6153 Q5902953 @default.
- Q64139342 P6153 Q89798279 @default.
- Q64139342 P6153 Q9004969 @default.
- Q64139342 P8363 Q78089383 @default.